Unknown

Dataset Information

0

Conserved IKAROS-regulated genes associated with B-progenitor acute lymphoblastic leukemia outcome.


ABSTRACT: Genetic alterations disrupting the transcription factor IKZF1 (encoding IKAROS) are associated with poor outcome in B lineage acute lymphoblastic leukemia (B-ALL) and occur in >70% of the high-risk BCR-ABL1+ (Ph+) and Ph-like disease subtypes. To examine IKAROS function in this context, we have developed novel mouse models allowing reversible RNAi-based control of Ikaros expression in established B-ALL in vivo. Notably, leukemias driven by combined BCR-ABL1 expression and Ikaros suppression rapidly regress when endogenous Ikaros is restored, causing sustained disease remission or ablation. Comparison of transcriptional profiles accompanying dynamic Ikaros perturbation in murine B-ALL in vivo with two independent human B-ALL cohorts identified nine evolutionarily conserved IKAROS-repressed genes. Notably, high expression of six of these genes is associated with inferior event-free survival in both patient cohorts. Among them are EMP1, which was recently implicated in B-ALL proliferation and prednisolone resistance, and the novel target CTNND1, encoding P120-catenin. We demonstrate that elevated Ctnnd1 expression contributes to maintenance of murine B-ALL cells with compromised Ikaros function. These results suggest that IKZF1 alterations in B-ALL leads to induction of multiple genes associated with proliferation and treatment resistance, identifying potential new therapeutic targets for high-risk disease.

SUBMITTER: Witkowski MT 

PROVIDER: S-EPMC5339666 | biostudies-literature | 2017 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications


Genetic alterations disrupting the transcription factor <i>IKZF1</i> (encoding IKAROS) are associated with poor outcome in B lineage acute lymphoblastic leukemia (B-ALL) and occur in >70% of the high-risk BCR-ABL1<sup>+</sup> (Ph<sup>+</sup>) and Ph-like disease subtypes. To examine IKAROS function in this context, we have developed novel mouse models allowing reversible RNAi-based control of Ikaros expression in established B-ALL in vivo. Notably, leukemias driven by combined BCR-ABL1 expressio  ...[more]

Similar Datasets

| S-EPMC7073093 | biostudies-literature
2022-11-17 | GSE209694 | GEO
2016-12-11 | GSE75976 | GEO
| S-EPMC5122860 | biostudies-other
| S-EPMC6232140 | biostudies-literature
| S-EPMC7084408 | biostudies-literature
| S-EPMC3902699 | biostudies-literature
| S-EPMC3555193 | biostudies-literature
| S-EPMC2783810 | biostudies-literature
| S-EPMC4968601 | biostudies-other